Rheumatoid arthritis epidemiology: a nationwide study in Poland.
Epidemiology
Incidence
Prevalence
Rheumatoid arthritis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
27 Apr 2024
27 Apr 2024
Historique:
received:
21
12
2023
accepted:
06
04
2024
medline:
28
4
2024
pubmed:
28
4
2024
entrez:
27
4
2024
Statut:
aheadofprint
Résumé
To assess the incidence and prevalence of rheumatoid arthritis (RA) in Poland for the period 2013-2021, total and dependent on gender, age, region and serological status. Information on reported National Health Fund (NHF) health services and reimbursed prescriptions were used, defining an RA patient as a person who had at least two visits in different quarters with ICD-10 code M05 or M06 and at the same time filled at least one reimbursed prescription for a drug whose active substance is methotrexate, sulfasalazine, leflunomide or was treated with biologic disease-modifying anti-rheumatic drugs (bDMRDs) or targeted synthetic DMARDs (tsDMARDs) as part of a drug program financed by the National Health Fund. The nationwide standardised incidence rate of RA in 2021 was 29 persons per 100,000 population (18 per 100,000 population of seropositive vs. 11 per 100,000 population of seronegative RA). The prevalence of RA in Poland in 2021 was 689.0 people per 100,000 population, a total of 0.7% (1.1% in women and 0.3% in men). The incidence of seronegative RA was approximately 38%. The majority of new RA diagnoses were in the sixth and seventh decades of life, irrespective of patients' gender. The results allow RA to be classified as a disease with a significant social impact. A trend of later onset of RA has been observed, which requires special consideration of the needs of patients over 55 years of age.
Identifiants
pubmed: 38678142
doi: 10.1007/s00296-024-05591-8
pii: 10.1007/s00296-024-05591-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Social Fund
ID : POWR.05.02.00-00-0149/15
Organisme : European Regional Development Fund
ID : POPC.02.02.00-00-0015/18-00
Informations de copyright
© 2024. The Author(s).
Références
Platzer A, Nussbaumer T, Karonitsch T, Smolen JS, Aletaha D (2019) Analysis of gene expression in rheumatoid arthritis and related conditions offers insights into sex-bias, gene biotypes and co-expression patterns. PLoS ONE 14(7):e0219698. https://doi.org/10.1371/journal.pone.0219698
doi: 10.1371/journal.pone.0219698
pubmed: 31344123
pmcid: 6657850
Gessl I, Hana CA, Deimel T, Durechova M, Hucke M, Konzett V, Popescu M, Studenic P, Supp G, Zauner M, Smolen JS, Aletaha D, Mandl P (2023) Tenderness and radiographic progression in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis 82(3):344–350. https://doi.org/10.1136/ard-2022-222787
doi: 10.1136/ard-2022-222787
pubmed: 36261248
Chen J, Li S, Zhu J, Su W, Jian C, Zhang J, Wu J, Wang T, Zhang W, Zeng F, Chang S, Jia L, Su J, Zhao Y, Wang J, Zeng F (2023) Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels. Arthritis Res Ther 25(1):74. https://doi.org/10.1186/s13075-023-03049-z
doi: 10.1186/s13075-023-03049-z
pubmed: 37138305
pmcid: 10155393
Koster F, Bakx PLH, Kok MR, Barreto DL, Weel-Koenders AEAM (2023) Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centred versus population-based comparison. Rheumatol Int 43(6):1067–1076. https://doi.org/10.1007/s00296-023-05282-w
doi: 10.1007/s00296-023-05282-w
pubmed: 36763167
pmcid: 10125938
Aletaha D (2022) The undifferentiated arthritis dilemma: the story continues. Nat Rev Rheumatol 18(4):189–190. https://doi.org/10.1038/s41584-022-00762-y
doi: 10.1038/s41584-022-00762-y
pubmed: 35228698
Studenic P, Aletaha D, de Wit M, Stamm TA, Alasti F, Lacaille D, Smolen JS, Felson DT (2023) American college of rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision. Arthritis Rheumatol 75(1):15–22. https://doi.org/10.1002/art.42347
doi: 10.1002/art.42347
pubmed: 36274193
Novella-Navarro M, Ruiz-Esquide V, Torres-Ortiz G, Chacur CA, Tornero C, Fernández-Fernández E, Monjo I, Sanmartí R, Plasencia-Rodríguez C, Balsa A (2023) A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification. Clin Exp Rheumatol 41(5):1114–1119. https://doi.org/10.55563/clinexprheumatol/7mscci
doi: 10.55563/clinexprheumatol/7mscci
pubmed: 36377568
World Health Organization (2018) Global health estimates 2016: disease burden by cause, age, sex, by country and by region, 2000–2016. World Health Organization, Geneva, p 2018
Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C (2021) The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 41(5):863–877. https://doi.org/10.1007/s00296-020-04731-0
doi: 10.1007/s00296-020-04731-0
pubmed: 33175207
Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, Almasi-Hashiani A, Ashrafi-Asgarabad A, Moradi-Lakeh M, Qorbani M, Collins G, Woolf AD, March L, Cross M (2019) Global, the regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis 78(11):1463–1471. https://doi.org/10.1136/annrheumdis-2019-215920
doi: 10.1136/annrheumdis-2019-215920
pubmed: 31511227
https://demografia.stat.gov.pl/bazademografia . Accessed 20 June 2023
Hedström AK, Rönnelid J, Klareskog L, Alfredsson L (2019) Complex relationships of smoking, HLA-DRB1 genes, and serologic profiles in patients with early rheumatoid arthritis: update from a Swedish population-based case–control study. Arthritis Rheumatol 71(9):1504–1511. https://doi.org/10.1002/art.40852
doi: 10.1002/art.40852
pubmed: 30742363
pmcid: 6771537
Chou YY, Lai KL, Chen DY, Lin CH, Chen HH (2015) Rheumatoid arthritis risk associated with periodontitis exposure: a nationwide, population-based cohort study. PLoS ONE 10(10):e0139693. https://doi.org/10.1371/journal.pone.0139693
doi: 10.1371/journal.pone.0139693
pubmed: 26426533
pmcid: 4591281
van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH (2011) Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 63(1):37–42. https://doi.org/10.1002/art.30100
doi: 10.1002/art.30100
pubmed: 20967854
Batko B, Stajszczyk M, Świerkot J, Urbański K, Raciborski F, Jędrzejewski M, Wiland P (2019) Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study. Arch Med Sci 15(1):134–140. https://doi.org/10.5114/aoms.2017.71371
doi: 10.5114/aoms.2017.71371
pubmed: 30697263
Silva-Fernández L, Macía-Villa C, Seoane-Mato D, Cortés-Verdú R, Romero-Pérez A, Quevedo-Vila V, Fábregas-Canales D, Antón-Pagés F, Añez G, Brandy A, Martínez-Dubois C, Rubio-Muñoz P, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S (2020) The prevalence of rheumatoid arthritis in Spain. Sci Rep 10(1):21551. https://doi.org/10.1038/s41598-020-76511-6
doi: 10.1038/s41598-020-76511-6
pubmed: 33299019
pmcid: 7725786
Scott IC, Whittle R, Bailey J, Twohig H, Hider SL, Mallen CD, Muller S, Jordan KP (2022) Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data. Lancet Reg Health Eur 23:100519. https://doi.org/10.1016/j.lanepe.2022.100519
doi: 10.1016/j.lanepe.2022.100519
pubmed: 36246147
pmcid: 9557034
Hense S, Luque Ramos A, Callhoff J, Albrecht K, Zink A, Hoffmann F (2016) Prävalenz der rheumatoiden Arthritis in Deutschland auf Basis von Kassendaten: Regionale Unterschiede und erste Ergebnisse der PROCLAIR-Studie [Prevalence of rheumatoid arthritis in Germany based on health insurance data: Regional differences and first results of the PROCLAIR study]. Z Rheumatol 75(8):819–827. https://doi.org/10.1007/s00393-016-0088-0 . (in German)
doi: 10.1007/s00393-016-0088-0
pubmed: 27120440
https://www.aihw.gov.au/reports/chronic-musculoskeletal-conditions/musculoskeletal-conditions/contents/arthritis/rheumatoid-arthritis . Accessed 16 May 2023
González-Chica DA, Vanlint S, Hoon E, Stocks N (2018) Epidemiology of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies and rheumatoid arthritis among 1.5 million patients in Australian general practice: NPS MedicineWise MedicineInsight dataset. BMC Musculoskelet Disord 19(1):20. https://doi.org/10.1186/s12891-018-1941-x
doi: 10.1186/s12891-018-1941-x
pubmed: 29347932
pmcid: 5774097
Abhishek A, Doherty M, Kuo CF, Mallen CD, Zhang W, Grainge MJ (2017) Rheumatoid arthritis is getting less frequent results in a nationwide population-based cohort study. Rheumatology (Oxford) 56(5):736–744. https://doi.org/10.1093/rheumatology/kew468
doi: 10.1093/rheumatology/kew468
pubmed: 28064207
Myasoedova E, Davis J, Matteson EL, Crowson CS (2020) Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014. Ann Rheum Dis 79(4):440–444. https://doi.org/10.1136/annrheumdis-2019-216694
doi: 10.1136/annrheumdis-2019-216694
pubmed: 32066556
Elfving P, Kononoff A, Huhtakangas J, Kautiainen H, Savolainen E, Arstila L, Barantseva J, Rannio T, Niinisalo H, Puolitaival A, Soininen K, Kariniemi S, Oksaranta M, Kaipiainen-Seppänen O (2023) Incidence of seropositive rheumatoid arthritis in population-based studies in Northern Savo, Finland, during 1980–2020. Rheumatol Int 43(4):659–666. https://doi.org/10.1007/s00296-022-05268-0
doi: 10.1007/s00296-022-05268-0
pubmed: 36629937
pmcid: 9833634
Muilu P, Rantalaiho V, Kautiainen H, Virta LJ, Eriksson JG, Puolakka K (2019) Increasing incidence and shifting profile of idiopathic inflammatory rheumatic diseases in adults during this millennium. Clin Rheumatol 38(2):555–562. https://doi.org/10.1007/s10067-018-4310-0
doi: 10.1007/s10067-018-4310-0
pubmed: 30259249
Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J (2013) Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken) 65(6):870–878. https://doi.org/10.1002/acr.21900
doi: 10.1002/acr.21900
pubmed: 23281173
Cai Y, Zhang J, Liang J, Xiao M, Zhang G, Jing Z, Lv L, Nan K, Dang X (2023) The burden of rheumatoid arthritis: findings from the 2019 global burden of diseases study and forecasts for 2030 by Bayesian age-period-cohort analysis. J Clin Med 12(4):1291. https://doi.org/10.3390/jcm12041291
doi: 10.3390/jcm12041291
pubmed: 36835827
pmcid: 9959633